• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Murmurs of Sharfstein replacement begin to circulate through social media

Murmurs of Sharfstein replacement begin to circulate through social media

January 7, 2011 By MedCity News

FDA logo

The Food & Drug Administration announced on Jan. 5 that its deputy commissioner, Joshua Sharfstein, would be leaving to take over Maryland’s health department.

The next day, MedCity News floated the idea of Cleveland Clinic cardiologist Dr. Steven Nissen replacing him.

“A Nissen nomination would symbolically show that Obama won’t back down from a fight with Republicans ’ and perhaps temporarily quiet liberal base that sees him as at best too willing to cave to the GOP and at worst weak, ineffectual and just another opportunistic politician without any strong core beliefs,” the publication wrote.

MedCity News logo

Immediate reaction to the idea through social media was subdued. Some loved the idea and envisioned a feistier FDA with Nissen on board. But others called the idea a “lead balloon.” Another exclaimed: “I hope not!”

Below is a sampling of reaction that pulsed through Twitter in the past 24 hours.

  • @cardiobrief Nissen mentioned as Sharfstein’s replacement, but the odds are very long: http://bit.ly/fyTlXD
  • @adamfeuerstein: If Steven Nissen is named as J. Sharfstein’s replacement at FDA, the biotech/drug stocks will tank and never recover. (via @cardiobrief) $$
  • @maverickny I hope Nissen gets the job, we need more spunk and rigour at the FDA not less
  • @tabloidmed: Sharfstein’s FDA replacement: Why not Cleveland Clinic’s Steven Nissen? \: http://bit.ly/fXgEts Wonder who floated that lead balloon?
  • @SMFleet Nissen should be named hot dog commissioner also.
  • @RPMReportMike great piece on Nissen and FDA. Not gonna happen, but worth thinking about nevertheless.
  • @ddwebster Oh, I hope not! RT @ChristianeTrue: RT @cardiobrief: Nissen mentioned as Sharfstein’s replacement-odds are very long http://bit.ly/fyTlXD

Coincidentally, on the same day MedCity News tossed Nissen’s name out as an FDA deputy, he was on air showing the kind of thinking that makes him worthy of consideration. He told Bloomberg that drugmakers need to make better drugs and not more of them.

Filed Under: Business/Financial News, Food & Drug Administration (FDA), News Well Tagged With: Gift Bans

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy